Cargando…
Maternal Pravastatin Prevents Altered Fetal Brain Development in a Preeclamptic CD-1 Mouse Model
OBJECTIVE: Using an animal model, we have previously shown that preeclampsia results in long-term adverse neuromotor outcomes in the offspring, and this phenotype was prevented by antenatal treatment with pravastatin. This study aims to localize the altered neuromotor programming in this animal mode...
Autores principales: | Carver, Alissa R., Andrikopoulou, Maria, Lei, Jun, Tamayo, Esther, Gamble, Phyllis, Hou, Zhipeng, Zhang, Jiangyang, Mori, Susumu, Saade, George R., Costantine, Maged M., Burd, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071009/ https://www.ncbi.nlm.nih.gov/pubmed/24963809 http://dx.doi.org/10.1371/journal.pone.0100873 |
Ejemplares similares
-
Is There a Causal Relation between Maternal Acetaminophen Administration and ADHD?
por: Saad, Antonio, et al.
Publicado: (2016) -
Pravastatin induces NO synthesis by enhancing microsomal arginine uptake in healthy and preeclamptic placentas
por: Pánczél, Zita, et al.
Publicado: (2019) -
Maternal—Fetal rejection reactions are unconstrained in preeclamptic women
por: Nguyen, Tina A., et al.
Publicado: (2017) -
Maternal-Fetal HLA Compatibility in Uncomplicated and Preeclamptic Naturally Conceived Pregnancies
por: van ‘t Hof, Liseanne J., et al.
Publicado: (2021) -
Maternal Low Volume Circulation Relates to Normotensive and Preeclamptic Fetal Growth Restriction
por: Gyselaers, Wilfried, et al.
Publicado: (2022)